0001209191-15-036093.txt : 20150424 0001209191-15-036093.hdr.sgml : 20150424 20150424162049 ACCESSION NUMBER: 0001209191-15-036093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150423 FILED AS OF DATE: 20150424 DATE AS OF CHANGE: 20150424 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daly James M CENTRAL INDEX KEY: 0001560782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 15792097 MAIL ADDRESS: STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336 CITY: WILMINGTON STATE: DE ZIP: 19880 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-04-23 0 0000879169 INCYTE CORP INCY 0001560782 Daly James M 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP, Chief Commercial Officer Common Stock 2015-04-23 4 M 0 1203 16.62 A 4724 D Common Stock 2015-04-23 4 M 0 15464 16.62 A 20188 D Common Stock 2015-04-23 4 M 0 5556 18.32 A 25744 D Common Stock 2015-04-23 4 S 0 22223 107.67 D 3521 D Common Stock 2015-04-23 4 M 0 14718 64.55 A 18239 D Common Stock 2015-04-23 4 S 0 14718 107.67 D 3521 D Non-Qualified Stock Option (right to buy) 16.62 2015-04-23 4 M 0 1203 0.00 D 2019-10-21 Common Stock 1203 3610 D Non-Qualified Stock Option (right to buy) 16.62 2015-04-23 4 M 0 15464 0.00 D 2019-10-21 Common Stock 15464 46391 D Non-Qualified Stock Option (right to buy) 18.32 2015-04-23 4 M 0 5556 0.00 D 2020-02-08 Common Stock 5556 22321 D Non-Qualified Stock Option (right to buy) 64.55 2015-04-23 4 M 0 14718 0.00 D 2021-01-20 Common Stock 14718 19624 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. Represents weighted average sale price. Actual sale prices ranged from $106.88 - $108.22. Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ Eric Siegel, Attorney-In-Fact 2015-04-24